Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SERIES A NON-VOTING CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY

v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SERIES A NON-VOTING CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY - USD ($)
Preferred Stock
Series A Non-Voting Convertible Preferred Stock
Tungsten support agreement
Preferred Stock
Series A Non-Voting Convertible Preferred Stock
Sealbond support agreement
Preferred Stock
Series A Non-Voting Convertible Preferred Stock
Preferred Stock
Series A-1 Non-Voting Convertible Preferred Stock
Preferred Stock
Series A-2 Non-Voting Convertible Preferred Stock
Common Stock
Registered Direct Offering
Common Stock
Additional Paid-In Capital
Registered Direct Offering
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Treasury Stock
Registered Direct Offering
Tungsten support agreement
Sealbond support agreement
Total
Balances, Beginning at Dec. 31, 2024                               $ 74,405,362
Balances, Beginning (in Shares) at Dec. 31, 2024                               2,213.8044
Increase (Decrease) in Temporary Equity [Roll Forward]                                
Accrual of paid-in-kind dividends on Series A Non-Voting Convertible Preferred Stock                               $ 1,256,662
Balances, Ending at Mar. 31, 2025                               $ 75,662,024
Balances, Ending (in Shares) at Mar. 31, 2025                               2,213.8044
Balances, Beginning at Dec. 31, 2024             $ 133   $ 67,856,589 $ (73,818,946) $ (3,862,987) $ (299,128)       $ (10,124,339)
Balances, Beginning (in shares) at Dec. 31, 2024             1,332,178                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Conversion of loan payable plus interest into Series A-1 NonVoting Convertible Preferred Stock       $ 24,994,461                       24,994,461
Conversion of loan payable plus interest into Series A-1 NonVoting Convertible Preferred Stock (in shares)       284.2638                        
Proceeds from issuance of common stock, net of fees           $ 58   $ 4,252,735         $ 4,252,793      
Proceeds from issuance of common stock, net of fees (in shares)           578,950                    
Accrual of paid-in-kind dividends on Series A Non-Voting Convertible Preferred Stock                 (1,256,662)             (1,256,662)
Share-based compensation expense                 84,474             84,474
Net loss                   (10,924,952)           (10,924,952)
Foreign currency translation adjustment                     61,156         61,156
Balances, Ending at Mar. 31, 2025       $ 24,994,461     $ 191   70,937,136 (84,743,898) (3,801,831) (299,128)       7,086,931
Balances, Ending (in shares) at Mar. 31, 2025       284.2638     1,911,128                  
Balances, Beginning at Dec. 31, 2024                               $ 74,405,362
Balances, Beginning (in Shares) at Dec. 31, 2024                               2,213.8044
Increase (Decrease) in Temporary Equity [Roll Forward]                                
Accrual of paid-in-kind dividends on Series A Non-Voting Convertible Preferred Stock                               $ (1,256,662)
Balances, Ending at Sep. 30, 2025                               70,126,957
Balances, Ending (in Shares) at Sep. 30, 2025     5,535,067 24,994,461                        
Balances, Beginning at Dec. 31, 2024             $ 133   67,856,589 (73,818,946) (3,862,987) (299,128)       (10,124,339)
Balances, Beginning (in shares) at Dec. 31, 2024             1,332,178                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Net loss                               (30,476,921)
Foreign currency translation adjustment                               2,226,852
Balances, Ending at Sep. 30, 2025         $ 9,800,839   $ 229   73,158,686 (104,295,867) (1,636,135) (299,128)       $ 7,258,152
Balances, Ending (in shares) at Sep. 30, 2025     166 284.2638 190.0572   2,293,162                 2,103.1494
Balances, Beginning at Mar. 31, 2025                               $ 75,662,024
Balances, Beginning (in Shares) at Mar. 31, 2025                               2,213.8044
Increase (Decrease) in Temporary Equity [Roll Forward]                                
Temporary Equity, Issuance of paid-in-kind dividends on Series A Non-Voting Convertible Preferred Stock (in shares)                               55.345
Balances, Ending at Jun. 30, 2025                               $ 75,662,024
Balances, Ending (in Shares) at Jun. 30, 2025                               2,269.1494
Balances, Beginning at Mar. 31, 2025       $ 24,994,461     $ 191   70,937,136 (84,743,898) (3,801,831) (299,128)       $ 7,086,931
Balances, Beginning (in shares) at Mar. 31, 2025       284.2638     1,911,128                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Issuance of common stock fees                 (548)             (548)
Share-based compensation expense                 65,027             65,027
Net loss                   (3,807,353)           (3,807,353)
Foreign currency translation adjustment                     3,534,542         3,534,542
Balances, Ending at Jun. 30, 2025       $ 24,994,461     $ 191   71,001,615 (88,551,251) (267,289) (299,128)       6,878,599
Balances, Ending (in shares) at Jun. 30, 2025       284.2638     1,911,128                  
Increase (Decrease) in Temporary Equity [Roll Forward]                                
Temporary Equity, Waiver of Series A Non-Voting Convertible Preferred Stock                           $ (533,500) $ (5,001,567)  
Temporary Equity, Waiver of Series A Non-Voting Convertible Preferred Stock (in shares)                           (16) (150)  
Balances, Ending at Sep. 30, 2025                               70,126,957
Balances, Ending (in Shares) at Sep. 30, 2025     5,535,067 24,994,461                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Issuance of stock in connection with the License Agreement with Serpin         $ 9,240,328   $ 38   2,108,790             11,349,156
Issuance of stock in connection with the License Agreement with Serpin (in shares)         179.1878   382,034                  
License Agreement transaction costs paid through the issuance of stock         $ 560,511                     560,511
License Agreement transaction costs paid through the issuance of stock (in shares)         10.8694                      
Waiver and Conversion of preferred stock $ 533,500 $ 5,001,567                       $ 533,500 $ 5,001,567  
Waiver of Series A Non-voting Convertible Preferred Stock (in shares) 16 150                            
Share-based compensation expense                 48,281             48,281
Net loss                   (15,744,616)           (15,744,616)
Foreign currency translation adjustment                     (1,368,846)         (1,368,846)
Balances, Ending at Sep. 30, 2025         $ 9,800,839   $ 229   73,158,686 (104,295,867) (1,636,135) (299,128)       $ 7,258,152
Balances, Ending (in shares) at Sep. 30, 2025     166 284.2638 190.0572   2,293,162                 2,103.1494
Balances, Beginning at Dec. 31, 2025                              
Balances, Beginning (in Shares) at Dec. 31, 2025                               0
Balances, Beginning at Dec. 31, 2025             $ 2,974   183,856,376 (108,076,316) (587,039) (299,128)       $ 74,896,867
Balances, Beginning (in shares) at Dec. 31, 2025             29,743,516                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Proceeds from issuance of common stock, net of fees             $ 234   11,397,225             11,397,459
Proceeds from issuance of common stock, net of fees (in shares)             2,338,948                  
Exercise of Warrants             $ 132                 132
Exercise of Warrants (in shares)             1,319,089                  
Share-based compensation expense                 449,419             449,419
Net loss                   (4,986,614)           (4,986,614)
Foreign currency translation adjustment                     (1,133,911)         (1,133,911)
Balances, Ending at Mar. 31, 2026             $ 3,340   195,703,020 (113,062,930) (1,720,950) (299,128)       80,623,352
Balances, Ending (in shares) at Mar. 31, 2026             33,401,553                  
Balances, Beginning at Dec. 31, 2025                              
Balances, Beginning (in Shares) at Dec. 31, 2025                               0
Balances, Ending at Sep. 30, 2026                              
Balances, Ending (in Shares) at Sep. 30, 2026                               0
Balances, Beginning at Dec. 31, 2025             $ 2,974   183,856,376 (108,076,316) (587,039) (299,128)       $ 74,896,867
Balances, Beginning (in shares) at Dec. 31, 2025             29,743,516                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Net loss                               (21,399,165)
Foreign currency translation adjustment                               (2,313,172)
Balances, Ending at Sep. 30, 2026             $ 3,413   196,804,626 (129,475,481) (2,900,211) (299,128)       64,133,219
Balances, Ending (in shares) at Sep. 30, 2026             34,129,553                  
Balances, Beginning at Mar. 31, 2026             $ 3,340   195,703,020 (113,062,930) (1,720,950) (299,128)       80,623,352
Balances, Beginning (in shares) at Mar. 31, 2026             33,401,553                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Exercise of Warrants             $ 23                 23
Exercise of Warrants (in shares)             228,000                  
Share-based compensation expense                 543,203             543,203
Net loss                   (11,529,609)           (11,529,609)
Foreign currency translation adjustment                     (1,270,861)         (1,270,861)
Balances, Ending at Jun. 30, 2026             $ 3,363   196,246,223 (124,592,539) (2,991,811) (299,128)       68,366,108
Balances, Ending (in shares) at Jun. 30, 2026             33,629,553                  
Balances, Ending at Sep. 30, 2026                              
Balances, Ending (in Shares) at Sep. 30, 2026                               0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Exercise of Warrants             $ 50                 $ 50
Exercise of Warrants (in shares)             500,000                  
Share-based compensation expense                 558,403             558,403
Net loss                   (4,882,942)           (4,882,942)
Foreign currency translation adjustment                     91,600         91,600
Balances, Ending at Sep. 30, 2026             $ 3,413   $ 196,804,626 $ (129,475,481) $ (2,900,211) $ (299,128)       $ 64,133,219
Balances, Ending (in shares) at Sep. 30, 2026             34,129,553